JP2020050628A - Antiseptic emulsion composition and antiseptic method - Google Patents
Antiseptic emulsion composition and antiseptic method Download PDFInfo
- Publication number
- JP2020050628A JP2020050628A JP2018183070A JP2018183070A JP2020050628A JP 2020050628 A JP2020050628 A JP 2020050628A JP 2018183070 A JP2018183070 A JP 2018183070A JP 2018183070 A JP2018183070 A JP 2018183070A JP 2020050628 A JP2020050628 A JP 2020050628A
- Authority
- JP
- Japan
- Prior art keywords
- polyhydric alcohol
- preservative
- emulsion composition
- less
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 239000000839 emulsion Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000002421 anti-septic effect Effects 0.000 title abstract description 10
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 56
- 230000002335 preservative effect Effects 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000003755 preservative agent Substances 0.000 claims abstract description 31
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 23
- 239000004094 surface-active agent Substances 0.000 claims abstract description 17
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 150000002009 diols Chemical class 0.000 claims description 10
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- -1 polyoxyethylene Polymers 0.000 description 39
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 36
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 239000000377 silicon dioxide Substances 0.000 description 16
- 239000004166 Lanolin Substances 0.000 description 11
- 235000019388 lanolin Nutrition 0.000 description 11
- 229940039717 lanolin Drugs 0.000 description 11
- 229920001296 polysiloxane Polymers 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000011163 secondary particle Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 150000003961 organosilicon compounds Chemical class 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011164 primary particle Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 239000012449 sabouraud dextrose agar Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical class OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- KVSKGMLNBAPGKH-UHFFFAOYSA-N tribromosalicylanilide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 KVSKGMLNBAPGKH-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- SQZBBBJJIMBYIW-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-4,4-dimethylpentane-1,3-dione Chemical compound COC1=CC=C(C(=O)CC(=O)C(C)(C)C)C=C1OC SQZBBBJJIMBYIW-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- OLZQCKXRHXVSRM-UHFFFAOYSA-N 2-(3-ethyl-1-phenylheptylidene)-1,3-dimethoxyimidazolidine-4,5-dione propanoic acid Chemical compound C(CC)(=O)O.C(C)C(CC(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC)CCCC OLZQCKXRHXVSRM-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SJQBHPJLLIJASD-UHFFFAOYSA-N 3,3',4',5-tetrachlorosalicylanilide Chemical compound OC1=C(Cl)C=C(Cl)C=C1C(=O)NC1=CC=C(Cl)C(Cl)=C1 SJQBHPJLLIJASD-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- AXJXRLHTQQONQR-UHFFFAOYSA-N 3-benzoylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 AXJXRLHTQQONQR-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- NPFYZDNDJHZQKY-UHFFFAOYSA-N 4-Hydroxybenzophenone Chemical class C1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 NPFYZDNDJHZQKY-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- AFUWHLXUBJOPNO-UHFFFAOYSA-N CCCCCCCCCCCCCCCC[SiH3] Chemical compound CCCCCCCCCCCCCCCC[SiH3] AFUWHLXUBJOPNO-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical group CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- ACIAHEMYLLBZOI-ZZXKWVIFSA-N Unsaturated alcohol Chemical compound CC\C(CO)=C/C ACIAHEMYLLBZOI-ZZXKWVIFSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- FYBYQXQHBHTWLP-UHFFFAOYSA-N bis(silyloxysilyloxy)silane Chemical compound [SiH3]O[SiH2]O[SiH2]O[SiH2]O[SiH3] FYBYQXQHBHTWLP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- UBHZUDXTHNMNLD-UHFFFAOYSA-N dimethylsilane Chemical compound C[SiH2]C UBHZUDXTHNMNLD-UHFFFAOYSA-N 0.000 description 1
- NIRGFSKAFYZMKI-UHFFFAOYSA-N diphenyl(silyl)silane Chemical compound C=1C=CC=CC=1[SiH]([SiH3])C1=CC=CC=C1 NIRGFSKAFYZMKI-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- DRUOQOFQRYFQGB-UHFFFAOYSA-N ethoxy(dimethyl)silicon Chemical compound CCO[Si](C)C DRUOQOFQRYFQGB-UHFFFAOYSA-N 0.000 description 1
- RSIHJDGMBDPTIM-UHFFFAOYSA-N ethoxy(trimethyl)silane Chemical compound CCO[Si](C)(C)C RSIHJDGMBDPTIM-UHFFFAOYSA-N 0.000 description 1
- CWAFVXWRGIEBPL-UHFFFAOYSA-N ethoxysilane Chemical compound CCO[SiH3] CWAFVXWRGIEBPL-UHFFFAOYSA-N 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- TXCSWUDCVVHMEH-UHFFFAOYSA-N ethyl 4-(diethoxyamino)benzoate Chemical compound CCON(OCC)C1=CC=C(C(=O)OCC)C=C1 TXCSWUDCVVHMEH-UHFFFAOYSA-N 0.000 description 1
- WQFMOOIFXWMCIR-UHFFFAOYSA-N ethyl 4-(dipropoxyamino)benzoate Chemical compound CCCON(OCCC)C1=CC=C(C(=O)OCC)C=C1 WQFMOOIFXWMCIR-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- KEHCHOCBAJSEKS-UHFFFAOYSA-N iron(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Fe+2] KEHCHOCBAJSEKS-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- PABHEXWDYRTPBQ-UHFFFAOYSA-N methyl 3-[2,5-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(C(C)C)=CC=C1C(C)C PABHEXWDYRTPBQ-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000005055 methyl trichlorosilane Substances 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 1
- JLUFWMXJHAVVNN-UHFFFAOYSA-N methyltrichlorosilane Chemical compound C[Si](Cl)(Cl)Cl JLUFWMXJHAVVNN-UHFFFAOYSA-N 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- LJZULWUXNKDPCG-UHFFFAOYSA-N nonane-1,2-diol Chemical compound CCCCCCCC(O)CO LJZULWUXNKDPCG-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920005553 polystyrene-acrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 150000003139 primary aliphatic amines Chemical class 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229950000975 salicylanilide Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- XYJRNCYWTVGEEG-UHFFFAOYSA-N trimethoxy(2-methylpropyl)silane Chemical compound CO[Si](OC)(OC)CC(C)C XYJRNCYWTVGEEG-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Abstract
Description
本発明は乳化組成物の防腐技術に関する。 The present invention relates to a technique for preserving an emulsified composition.
化粧料等の皮膚外用剤には、水分、油分の他、増粘剤、保湿剤などが配合されており、微生物の繁殖に適した条件が揃っている場合が多い。そのため、皮膚外用剤が工場で生産され流通過程を経て消費者の手に渡り、さらに開封からその化粧料が消費されるまでの間に、偶発的に微生物が混入し汚染される危険性がある。皮膚外用剤が微生物に汚染されると、異臭の発生、変色、品質の劣化を招くだけでなく、配合成分の変質による皮膚障害、病原菌による感染症、菌体成分や代謝産物による皮膚障害が引き起こされる可能性がある。 Skin external preparations such as cosmetics contain a thickener, a humectant, and the like in addition to water and oil, and often have conditions suitable for propagation of microorganisms. Therefore, there is a danger that microbes are accidentally mixed in and contaminated during the period from when the external preparation for skin is produced at the factory and distributed to the consumer through the distribution process and further until the cosmetic is consumed after opening. . Microorganisms contaminating skin preparations not only cause off-flavors, discoloration, and quality deterioration, but also cause skin damage due to deterioration of the ingredients, infectious diseases caused by pathogenic bacteria, and skin damage caused by bacterial components and metabolites. Could be
このため、皮膚外用剤の微生物汚染の対策として、各種の抗菌・防腐剤を添加することが一般的に行われている。従来より皮膚外用剤の防腐剤としてはパラベン(パラオキシ安息香酸エステル)が最も広く使用されている(例えば特許文献1)。
また、乳化形態をとる皮膚外用剤においては、乳化のために配合されている界面活性剤が一定の抗菌効果を有することが知られている(例えば非特許文献1)。
つまり、乳化形態をとる皮膚外用剤においては、防腐剤と界面活性剤の二重の効果により抗菌性が達成されているといえる。
For this reason, it is common practice to add various antibacterial and preservatives as a measure against microbial contamination of the external preparation for skin. Conventionally, paraben (paraoxybenzoic acid ester) has been most widely used as a preservative for a skin external preparation (for example, Patent Document 1).
It is known that in a skin external preparation in an emulsified form, a surfactant incorporated for emulsification has a certain antibacterial effect (for example, Non-Patent Document 1).
In other words, it can be said that the skin external preparation in an emulsified form achieves the antibacterial property by the dual effect of the preservative and the surfactant.
ところで、近年、肌への刺激の少なさから、いわゆる界面活性剤フリーの乳化組成物からなる化粧料が注目されている。界面活性剤フリーの乳化組成物としては、ピッカリングエマルション(例えば特許文献2)や、高分子乳化組成物(例えば特許文献3)が挙げられる。 By the way, in recent years, cosmetics comprising a so-called surfactant-free emulsion composition have attracted attention because of less irritation to the skin. Examples of the surfactant-free emulsion composition include a Pickering emulsion (for example, Patent Document 2) and a polymer emulsion composition (for example, Patent Document 3).
上述の通り、通常の乳化形態をとる皮膚外用剤においては、防腐剤と界面活性剤の抗菌作用により、微生物による汚染から守られている。しかし、いわゆる界面活性剤フリーの乳化組成物、具体的にはピッカリングエマルションや高分子乳化組成物においては、界面活性剤による抗菌作用が得られないため、防腐性に劣るという問題があった。 As described above, a skin external preparation in a usual emulsified form is protected from microbial contamination by the antibacterial action of a preservative and a surfactant. However, in a so-called surfactant-free emulsion composition, specifically, a Pickering emulsion or a polymer emulsion composition, the antibacterial action of the surfactant cannot be obtained, so that there is a problem that the preservability is poor.
このような問題に鑑み、本発明の解決しようとする課題は、界面活性剤フリーの乳化組成物の新規の防腐技術を提供することにある。 In view of such problems, an object of the present invention is to provide a novel preservative technique for a surfactant-free emulsion composition.
上述の課題を解決する本発明は、融点が80℃以下である、重量平均分子量5,000未満の低分子界面活性剤を、乳化系を維持するために必要な含有量で含まない乳化組成物であって、(A)環状構造を含まない炭素数が5以上の多価アルコールと、(B)防腐剤(但し、前記炭素数が5以上の多価アルコールを除く)と、(C)粉体を含むことを特徴とする乳化組成物である。
本発明の乳化組成物は、(A)炭素数が5以上の多価アルコール、(B)防腐剤及び(C)粉体の相乗効果により、優れた防腐性を発揮する。
The present invention for solving the above-mentioned problems has an emulsified composition which does not contain a low-molecular surfactant having a melting point of 80 ° C. or less and a weight average molecular weight of less than 5,000 in a content necessary for maintaining an emulsified system. (A) a polyhydric alcohol having 5 or more carbon atoms not containing a cyclic structure, (B) a preservative (excluding the polyhydric alcohol having 5 or more carbon atoms), and (C) powder An emulsified composition comprising a body.
The emulsified composition of the present invention exhibits excellent preservative properties due to the synergistic effect of (A) a polyhydric alcohol having 5 or more carbon atoms, (B) a preservative, and (C) a powder.
本発明の好ましい形態では、前記(C)粉体により安定化されているピッカリングエマルションである。
ピッカリングエマルションの形態とすることにより、安定な乳化組成物を得ることができる。
In a preferred embodiment of the present invention, the pickling emulsion is stabilized by the powder (C).
By using a Pickering emulsion, a stable emulsion composition can be obtained.
本発明の好ましい形態では、(A)の多価アルコールとして、少なくとも1位及び2位に水酸基を有する炭素数が5以上の多価アルコールを含む。
このような多価アルコールを用いることにより、より優れた防腐性を得ることができる。
In a preferred embodiment of the present invention, the polyhydric alcohol (A) includes a polyhydric alcohol having a hydroxyl group at at least 1-position and 2-position and having 5 or more carbon atoms.
By using such a polyhydric alcohol, more excellent preservability can be obtained.
本発明の好ましい形態では、(A)の多価アルコールとして、炭素数が5以上のジオールを含む。
炭素数が5以上のジオールを含む本発明の乳化組成物は、より優れた防腐性を有する。
In a preferred embodiment of the present invention, the polyhydric alcohol (A) includes a diol having 5 or more carbon atoms.
The emulsified composition of the present invention containing a diol having 5 or more carbon atoms has better antiseptic properties.
本発明の好ましい形態では、(D)環状構造を含まない炭素数が4以下の多価アルコールを含む。
このような多価アルコールを含むことにより、乳化組成物の安定性を向上させることができる。
In a preferred embodiment of the present invention, (D) a polyhydric alcohol having 4 or less carbon atoms not containing a cyclic structure is included.
By including such a polyhydric alcohol, the stability of the emulsified composition can be improved.
本発明の好ましい形態では、(D)の多価アルコールとして、炭素数が4以下のジオールを含む。
炭素数が4以下のジオールを用いることにより、より安定性に優れた乳化組成物を提供することができる。
In a preferred embodiment of the present invention, the polyhydric alcohol (D) includes a diol having 4 or less carbon atoms.
By using a diol having 4 or less carbon atoms, an emulsified composition having better stability can be provided.
本発明の乳化組成物は皮膚外用剤の形態とすることが好ましい。 The emulsion composition of the present invention is preferably in the form of a skin external preparation.
本発明は、融点が80℃以下である、重量平均分子量5,000未満の低分子界面活性剤を実質的に含まない、乳化組成物の防腐方法であって、(A)環状構造を含まない炭素数が5以上の多価アルコールと、(B)防腐剤(但し、前記炭素数が5以上の多価アルコールを除く)と、(C)粉体とを添加することを特徴とする、防腐方法にも関する。
本発明の防腐方法によれば、微生物により汚染されやすい界面活性剤フリーの乳化組成物の防腐性を向上させることができる。
The present invention is a method for preserving an emulsified composition substantially free of a low-molecular surfactant having a melting point of 80 ° C. or lower and having a weight average molecular weight of less than 5,000, and (A) containing no cyclic structure A preservative, characterized by adding a polyhydric alcohol having 5 or more carbon atoms, (B) a preservative (excluding the polyhydric alcohol having 5 or more carbon atoms), and (C) a powder. Also about the method.
According to the preservation method of the present invention, the preservability of a surfactant-free emulsion composition that is easily contaminated by microorganisms can be improved.
本発明の好ましい形態では、さらに(D)環状構造を含まない炭素数が4以下の多価アルコールを添加する。
このような多価アルコールを添加することにより、乳化組成物の安定性を向上させることができる。
In a preferred embodiment of the present invention, (D) a polyhydric alcohol having 4 or less carbon atoms not containing a cyclic structure is further added.
The stability of the emulsified composition can be improved by adding such a polyhydric alcohol.
本発明の乳化組成物は防腐性に優れる。また、本発明の防腐方法によれば、いわゆる界面活性剤フリーの乳化組成物の防腐性を向上させることができる。 The emulsified composition of the present invention has excellent antiseptic properties. Further, according to the preservative method of the present invention, the preservability of a so-called surfactant-free emulsion composition can be improved.
<1>乳化組成物
以下、本発明の乳化組成物の実施形態についてさらに詳しく説明を加える。
本発明の乳化組成物は、融点が80℃以下である、重量平均分子量5,000未満の低分子界面活性剤(以下、単に低分子界面活性剤ともいう)を、乳化系を維持するために必要な含有量で含まない。
<1> Emulsion composition Hereinafter, embodiments of the emulsification composition of the present invention will be described in more detail.
The emulsified composition of the present invention comprises a low-molecular surfactant having a melting point of 80 ° C. or less and a weight average molecular weight of less than 5,000 (hereinafter, also simply referred to as a low-molecular surfactant) in order to maintain an emulsified system. Not included in required content.
例えば低分子界面活性剤の含有量が、好ましくは0.5質量%以下、より好ましくは0.1質量%以下、さらに好ましくは0.01質量%以下のとき、低分子界面活性剤を「乳化系を維持するために必要な含有量で含まない」ということができる。 For example, when the content of the low-molecular surfactant is preferably 0.5% by mass or less, more preferably 0.1% by mass or less, and still more preferably 0.01% by mass or less, the low-molecular-weight surfactant is emulsified. It is not contained in the content necessary for maintaining the system. "
低分子界面活性剤としては、通常、乳化化粧料に用いられる非イオン性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤及び両性界面活性剤が挙げられる。 Examples of the low molecular surfactant include a nonionic surfactant, an anionic surfactant, a cationic surfactant and an amphoteric surfactant which are usually used in emulsified cosmetics.
非イオン性界面活性剤の例としては、ポリオキシエチレンアルキルエーテル類、ポリオキシエチレン硬化ヒマシ油類、ポリオキシエチレンソルビタン脂肪酸エステル類、ソルビタン脂肪酸エステル類、ポリエチレングリコール脂肪酸エステル類、ポリオキシエチレンソルビット脂肪酸エステル類、ポリグリセリン脂肪酸エステル類、アルキルグリセリンエーテル類、グリセリン脂肪酸エステル類、ポリオキシエチレンコレステリルエーテル類、アルキルポリグルコシド類、ショ糖脂肪酸エステル類、アミンオキシド類、等が挙げられる。 Examples of nonionic surfactants include polyoxyethylene alkyl ethers, polyoxyethylene hydrogenated castor oils, polyoxyethylene sorbitan fatty acid esters, sorbitan fatty acid esters, polyethylene glycol fatty acid esters, polyoxyethylene sorbit fatty acid Esters, polyglycerin fatty acid esters, alkyl glycerin ethers, glycerin fatty acid esters, polyoxyethylene cholesteryl ethers, alkyl polyglucosides, sucrose fatty acid esters, amine oxides, and the like.
アニオン性界面活性剤の例としては、アルキルサルフェート類、アルキルアミドエーテルサルフェート類、アルキルスルホナート類、α−オレフィンスルホン酸類、アルキルアミドスルホナート類、アルキルアリールスルホナート類、アルキルホスフェート類、ポリオキシエチレンアルキルエーテルホスフェート類、アシルサルコシナート類、及びアシルタウリン塩類、等が挙げられる。 Examples of anionic surfactants include alkyl sulfates, alkyl amide ether sulfates, alkyl sulfonates, α-olefin sulfonic acids, alkyl amide sulfonates, alkyl aryl sulfonates, alkyl phosphates, polyoxyethylene Alkyl ether phosphates, acyl sarcosinates, acyl taurine salts, and the like.
両性界面活性剤の例としては、アルキル酢酸ベタイン類、アルキルイミダゾリニウムベタイン類、アルキルアミドベタイン類、アルキルスルホベタイン類、等が挙げられる。 Examples of the amphoteric surfactant include alkyl acetate betaines, alkyl imidazolinium betaines, alkyl amide betaines, alkyl sulfo betaines, and the like.
カチオン性界面活性剤の例としては、ポリオキシアルキレン化されていてもよい、第1級、第2級又は第3級脂肪族アミンの塩類、及び、第4級アンモニウム塩類、等が挙げられる。 Examples of cationic surfactants include salts of primary, secondary or tertiary aliphatic amines, which may be polyoxyalkylenated, and quaternary ammonium salts.
本来、ピッカリングエマルションのような低分子の界面活性剤を含まない乳化組成物は防腐性に劣る。しかし、本発明の乳化組成物は、(A)環状構造を含まない炭素数が5以上の多価アルコール、(B)防腐剤及び(C)粉体の相乗効果により、優れた防腐性を発揮する。以下、「(A)環状構造を含まない炭素数が5以上の多価アルコール」、「(B)防腐剤」及び「(C)粉体」について説明を加える。 Essentially, an emulsified composition such as a Pickering emulsion that does not contain a low-molecular surfactant has poor antiseptic properties. However, the emulsified composition of the present invention exhibits excellent antiseptic properties due to the synergistic effect of (A) a polyhydric alcohol having 5 or more carbon atoms not containing a cyclic structure, (B) a preservative, and (C) a powder. I do. Hereinafter, “(A) a polyhydric alcohol having 5 or more carbon atoms not containing a cyclic structure”, “(B) preservative”, and “(C) powder” will be described.
本発明の乳化組成物は(A)環状構造を含まない炭素数が5以上の多価アルコールを必須成分として含む。
(A)の環状構造を含まない多価アルコールの炭素数は5以上であれば特に限定されないが、好ましくは5〜10、より好ましくは5〜8、さらに好ましくは5〜6である。
(A)の多価アルコールは、飽和アルコールであっても不飽和アルコールであってもよいが、飽和アルコールであることが好ましい。
The emulsion composition of the present invention contains (A) a polyhydric alcohol having 5 or more carbon atoms not containing a cyclic structure as an essential component.
The carbon number of the polyhydric alcohol having no cyclic structure in (A) is not particularly limited as long as it is 5 or more, but is preferably 5 to 10, more preferably 5 to 8, and even more preferably 5 to 6.
The polyhydric alcohol (A) may be a saturated alcohol or an unsaturated alcohol, but is preferably a saturated alcohol.
また、(A)の多価アルコールの水酸基の数は、好ましくは2〜5、より好ましくは2〜4、さらに好ましくは2〜3、さらに好ましくは2である。つまり、(A)の多価アルコールとしては、ジオールが特に好ましく例示できる。 Further, the number of hydroxyl groups of the polyhydric alcohol (A) is preferably 2 to 5, more preferably 2 to 4, further preferably 2 to 3, and further preferably 2. That is, the polyhydric alcohol (A) is particularly preferably a diol.
(A)の多価アルコールにおける水酸基が結合する位置は特に制限されないが、末端(つまり1位)に水酸基が結合していることが好ましい。また、少なくとも1位及び2位に水酸基を有する多価アルコールを特に好ましく例示することができる。 The position where the hydroxyl group in the polyhydric alcohol (A) is bonded is not particularly limited, but it is preferable that the hydroxyl group is bonded to the terminal (that is, the first position). Particularly preferred are polyhydric alcohols having a hydroxyl group at least at the 1- and 2-positions.
(A)の多価アルコールとしては、特に1位及び2位に水酸基を有するジオールが好ましく例示できる。
このようなジオールとしては、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−ヘプタンジオール、1,2−オクタンジオール、1,2−ノナンジオール及び1,2−デカンジオールなどが挙げられ、特に1,2−ペンタンジオール及び1,2−ヘキサンジオールを好適に例示できる。
Preferred examples of the polyhydric alcohol (A) include diols having a hydroxyl group at the 1-position and the 2-position.
Examples of such diols include 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, and the like. Suitable examples include 1,2-pentanediol and 1,2-hexanediol.
本発明の乳化組成物における(A)の多価アルコールの含有量は、防腐性の向上の観点からは、好ましくは0.01質量%以上、より好ましくは0.1質量%以上、さらに好ましくは0.5質量%以上、さらに好ましくは1質量%以上である。 The content of the polyhydric alcohol (A) in the emulsified composition of the present invention is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and still more preferably from the viewpoint of improving the preservability. It is at least 0.5% by mass, more preferably at least 1% by mass.
また、本発明の乳化組成物における(A)の多価アルコールの含有量は、乳化組成物の安定性の観点からは、好ましくは30質量%以下、より好ましくは20質量%以下、さらに好ましくは15質量%以下、さらに好ましくは10質量%以下、さらに好ましくは7質量%以下、さらに好ましくは4質量%以下である。 In addition, the content of the polyhydric alcohol (A) in the emulsion composition of the present invention is preferably 30% by mass or less, more preferably 20% by mass or less, and still more preferably from the viewpoint of the stability of the emulsion composition. It is at most 15% by mass, more preferably at most 10% by mass, further preferably at most 7% by mass, further preferably at most 4% by mass.
(B)防腐剤としては、一般的に皮膚外用剤において防腐剤として用いられているものであれば特に制限なく用いることができる。具体的には、フェノキシエタノール、安息香酸およびその塩類、サリチル酸およびその塩類、フェノール、ソルビン酸およびその塩類、デヒドロ酢酸およびその塩類、パラオキシ安息香酸エステル類(例えばメチルパラベン、エチルパラベン、ブチルパラベンなど)、クロルクレゾール、ヘキサクロロフェン、レゾルシン、イソプロピルメチルフェノール、オルトフェニルフェノール、塩化ベンザルコニウム、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、臭化アルキルイソキノリウム、トリクリリカルバニリド、ハロカルバン、感光素201号、トリクロロヒドロキシジフェニルエーテル(トリクロサン)、メチルクロロイソチアゾリノン・メチルイソチアゾリノン液、ビサボロール、塩酸アルキルジアミノエチルグリシン、トリクロロ・サリチルアニリド(TCSA)、トリブロモ・サリチルアニリド(TBS)等が挙げられる。
(B)防腐剤は1種のみを用いてもよいし、また、2種以上を組み合わせて用いてもよい。
The preservative (B) can be used without any particular limitation as long as it is generally used as a preservative in a skin external preparation. Specifically, phenoxyethanol, benzoic acid and its salts, salicylic acid and its salts, phenol, sorbic acid and its salts, dehydroacetic acid and its salts, paraoxybenzoic acid esters (eg, methylparaben, ethylparaben, butylparaben, etc.), chlor Cresol, hexachlorophen, resorcin, isopropylmethylphenol, orthophenylphenol, benzalkonium chloride, chlorhexidine hydrochloride, chlorhexidine gluconate, alkylisoquinolium bromide, tricrycarbanilide, halocarban, photosensitizer 201, trichlorohydroxydiphenyl ether (Triclosan), methylchloroisothiazolinone / methylisothiazolinone liquid, bisabolol, alkyldiaminoethylglycine hydrochloride, Lolo salicylanilide (TCSA), tribromo-salicylanilide (TBS), and the like.
(B) As the preservative, only one kind may be used, or two or more kinds may be used in combination.
乳化組成物における(B)防腐剤の含有量は、防腐性の向上の観点から、好ましくは0.01質量%以上、より好ましくは0.1質量%以上、さらに好ましくは0.5質量%以上である。 The content of the preservative (B) in the emulsion composition is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, further preferably 0.5% by mass or more, from the viewpoint of improving the preservability. It is.
また、乳化組成物における(B)防腐剤の含有量は、肌への刺激を低減する観点から、好ましくは5質量%以下、より好ましくは3質量%以下、さらに好ましくは2質量%以下である。 In addition, the content of the preservative (B) in the emulsion composition is preferably 5% by mass or less, more preferably 3% by mass or less, and still more preferably 2% by mass or less, from the viewpoint of reducing skin irritation. .
乳化組成物における(A)の多価アルコールと、(B)の防腐剤の含有質量比は、好ましくは100:1〜1:10、より好ましくは50:1〜1:5、さらに好ましくは20:1〜1:3、さらに好ましくは7:1〜1:1、さらに好ましくは4:1〜2:1である。
(A)と(B)の比率を前記範囲とすることにより、乳化組成物の防腐性と安定性を向上させることができる。
The content ratio by mass of the polyhydric alcohol (A) to the preservative (B) in the emulsion composition is preferably 100: 1 to 1:10, more preferably 50: 1 to 1: 5, and further preferably 20. : 1 to 1: 3, more preferably 7: 1 to 1: 1, and more preferably 4: 1 to 2: 1.
By setting the ratio of (A) and (B) within the above range, the preservability and stability of the emulsified composition can be improved.
本発明の乳化組成物は(C)粉体を含む。(C)粉体はどのような態様で含まれていても良いが、油相と水相の界面に存在する態様で含まれていることが好ましい。すなわち、本発明の乳化組成物は(C)により安定化されたピッカリングエマルションの形態とすることが好ましい。 The emulsified composition of the present invention contains (C) a powder. (C) The powder may be contained in any form, but is preferably contained in a form present at the interface between the oil phase and the aqueous phase. That is, the emulsion composition of the present invention is preferably in the form of a pickering emulsion stabilized by (C).
(C)粉体としては、表面がコーティングされていてもよい、二酸化チタン、酸化スズ、シリカ、酸化鉄、粘土鉱物、酸化アルミニウム、ナノ微粒子沈降炭酸カルシウム、石炭、酸化マグネシウム、三ケイ酸マグネシウムなどの無機粉体、並びにエチルセルロース、結晶性脂肪アルコール及び脂肪酸、樹脂粒子(例えばポリスチレン又はポリメタクリレート)などの有機粉体の何れをも用いることができる。 (C) As powder, titanium dioxide, tin oxide, silica, iron oxide, clay mineral, aluminum oxide, nano-particle precipitated calcium carbonate, coal, magnesium oxide, magnesium trisilicate, etc., whose surface may be coated And inorganic powders such as ethyl cellulose, crystalline fatty alcohols and fatty acids, and resin particles (eg, polystyrene or polymethacrylate).
(C)粉体としてシリカを用いる場合には、例えば、ケイ素ハロゲン化物の蒸気相酸化により生成される、いわゆる乾式シリカ粉末、及び水ガラス等から製造される、いわゆる湿式シリカ粉末の何れを用いてもよい。
乾式シリカ粉末としては、例えばAerosilシリーズ(日本アエロジル株式会社)、CAB−O−SILシリーズ(キャボットコーポレーション)、HDKシリーズ(旭化成ワッカーシリコーン株式会社)、湿式シリカ粉末としては、例えばNipsilシリーズ(東ソー・シリカ株式会社)、HI−SILシリーズ(PPG)等の市販品を用いることができる。
(C) When silica is used as the powder, for example, any of a so-called dry silica powder produced by vapor phase oxidation of a silicon halide and a so-called wet silica powder produced from water glass or the like is used. Is also good.
Examples of dry silica powder include Aerosil series (Nippon Aerosil Co., Ltd.), CAB-O-SIL series (Cabot Corporation), HDK series (Asahi Kasei Wacker Silicone Co., Ltd.), and examples of wet silica powder include Nipsil series (Tosoh Silica). And HI-SIL series (PPG).
(C)粉体としてシリカや酸化金属を用いる場合には、その表面を疎水化処理することが好ましい。
疎水化処理としては、有機ケイ素化合物、シリコーン、炭化水素油、脂肪酸、脂肪酸アミド、脂肪酸エステル、高級アルコール、ポリオキシアルキレン化合物等の疎水化処理剤で粉体を処理する方法が挙げられる。
特に好ましくは、有機ケイ素化合物又はシリコーンを疎水化処理剤として粉体を処理する。
(C) In the case where silica or metal oxide is used as the powder, the surface thereof is preferably subjected to a hydrophobic treatment.
Examples of the hydrophobizing treatment include a method of treating a powder with a hydrophobizing agent such as an organosilicon compound, silicone, hydrocarbon oil, fatty acid, fatty acid amide, fatty acid ester, higher alcohol, or polyoxyalkylene compound.
Particularly preferably, the powder is treated using an organosilicon compound or silicone as a hydrophobizing agent.
有機ケイ素化合物としては、ヘキサメチルジシラザン、モノメチルシラン、ジメチルシラン、トリメチルシラン、トリメチルエトキシシラン、イソブチルトリメトキシシラン、トリメチルクロロシラン、ジメチルジクロロシラン、メチルトリクロロシラン、ジメチルエトキシシラン、ジメチルジメトキシシラン、ジフェニルジエトキシシラン、ヘキサメチルジシロキサン、パルミチルシラン等が挙げられる。これらは一種或いは二種以上の混合物で用いられる。 Examples of the organosilicon compound include hexamethyldisilazane, monomethylsilane, dimethylsilane, trimethylsilane, trimethylethoxysilane, isobutyltrimethoxysilane, trimethylchlorosilane, dimethyldichlorosilane, methyltrichlorosilane, dimethylethoxysilane, dimethyldimethoxysilane, and diphenyldisilane. Ethoxysilane, hexamethyldisiloxane, palmitylsilane and the like can be mentioned. These are used in one kind or in a mixture of two or more kinds.
シリコーンとしては、ジメチルシリコーン、メチルフェニルシリコーン、α−メチルスチレン変性シリコーン、クロルフェニルシリコーン、フッ素変性シリコーン等が挙げられる。 Examples of the silicone include dimethyl silicone, methylphenyl silicone, α-methylstyrene-modified silicone, chlorophenyl silicone, and fluorine-modified silicone.
乳化組成物における(C)粉体の含有量は、特に限定されないが、好ましくは0.1〜5質量%、より好ましくは0.5〜2質量%とすることができる。 The content of the powder (C) in the emulsion composition is not particularly limited, but may be preferably 0.1 to 5% by mass, and more preferably 0.5 to 2% by mass.
また、(D)環状構造を含まない炭素数が4以下の多価アルコールを含む形態とすることにより、乳化組成物の安定性を向上させることができる。 In addition, the stability of the emulsified composition can be improved by using (D) a form containing a polyhydric alcohol having 4 or less carbon atoms not containing a cyclic structure.
(D)の多価アルコールの炭素数は、4以下であれば特に限定されないが、好ましくは2〜4、より好ましくは3〜4、さらに好ましくは4である。 The carbon number of the polyhydric alcohol of (D) is not particularly limited as long as it is 4 or less, but is preferably 2 to 4, more preferably 3 to 4, and still more preferably 4.
(D)の多価アルコールにおける水酸基の数は、好ましくは2〜4、より好ましくは2〜3、さらに好ましくは2である。つまり、(D)の多価アルコールとしては、ジオールが特に好ましく例示できる。 The number of hydroxyl groups in the polyhydric alcohol (D) is preferably 2 to 4, more preferably 2 to 3, and still more preferably 2. That is, the polyhydric alcohol (D) is particularly preferably a diol.
(D)の多価アルコールにおける水酸基が結合する位置は特に制限されないが、末端(つまり1位)に水酸基が結合していることが好ましい。また、1位及び2位あるいは1位及び3位に水酸基を有する多価アルコールを特に好ましく例示することができる。 The position where the hydroxyl group in the polyhydric alcohol (D) is bonded is not particularly limited, but it is preferable that the hydroxyl group is bonded to the terminal (that is, the 1-position). Particularly preferred are polyhydric alcohols having a hydroxyl group at the 1- and 2-positions or at the 1- and 3-positions.
(D)の多価アルコールとしては、1,2−ブチレングリコール、1,3−ブチレングリコール、1,2−プロピレングリコール、1,3−プロピレングリコール、1,2−エチレングリコールを好ましく例示することができ、特に1,3−ブチレングリコールを好ましく例示できる。 Preferred examples of the polyhydric alcohol (D) include 1,2-butylene glycol, 1,3-butylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, and 1,2-ethylene glycol. And particularly preferably 1,3-butylene glycol.
乳化組成物における(D)の多価アルコールの含有量は、乳化組成物の安定性を向上させる観点から、好ましくは0.5質量%以上、より好ましくは1質量%以上、さらに好ましくは2質量%以上、さらに好ましくは3質量%以上である。 The content of the polyhydric alcohol (D) in the emulsion composition is preferably 0.5% by mass or more, more preferably 1% by mass or more, and still more preferably 2% by mass, from the viewpoint of improving the stability of the emulsion composition. %, More preferably 3% by mass or more.
また、乳化組成物における(D)の多価アルコールの含有量の上限に特に制限はないが、製品設計上、好ましくは20質量%以下、より好ましくは10質量%以下を目安とすることができる。 The upper limit of the content of the polyhydric alcohol (D) in the emulsified composition is not particularly limited, but it is preferably 20% by mass or less, more preferably 10% by mass or less in terms of product design. .
(A)の多価アルコールと(D)の多価アルコールの含有質量比は、好ましくは1:10〜10:1、より好ましくは1:5〜5:1、さらに好ましくは1:4〜4:1、さらに好ましくは1:3〜3:1である。
(A)と(D)の比率を前記範囲とすることにより、乳化組成物の防腐性と安定性を向上させることができる。
The mass ratio of the polyhydric alcohol (A) to the polyhydric alcohol (D) is preferably 1:10 to 10: 1, more preferably 1: 5 to 5: 1, and still more preferably 1: 4 to 4. : 1, more preferably 1: 3 to 3: 1.
By setting the ratio of (A) to (D) in the above range, the preservability and stability of the emulsified composition can be improved.
本発明の乳化組成物をピッカリングエマルションの形態とする場合には、乳化粉体の平均一次粒子径は、1〜1000nmを目安とすることができ、好ましくは3〜100nm、より好ましくは5〜30nmである。 When the emulsified composition of the present invention is in the form of a Pickering emulsion, the average primary particle diameter of the emulsified powder can be 1 to 1000 nm as a guide, preferably 3 to 100 nm, more preferably 5 to 100 nm. 30 nm.
また、乳化粉体の平均二次粒子径は、好ましくは1μm以下を目安とすることができ、好ましくは500nm以下、さらに好ましくは100nm以下、さらに好ましくは50nm以下である。
ここで、平均一次粒子径及び平均二次粒子径は、走査型電子顕微鏡像上で2500個以上の粒子の最大径を測定し、その個数平均を算出することにより求めることができる。
なお、平均二次粒子径は乳化を行う際に組成物に加える応力によって調整することができる。
The average secondary particle diameter of the emulsified powder can be preferably about 1 μm or less, preferably 500 nm or less, more preferably 100 nm or less, and further preferably 50 nm or less.
Here, the average primary particle diameter and the average secondary particle diameter can be determined by measuring the maximum diameter of 2500 or more particles on a scanning electron microscope image and calculating the number average.
The average secondary particle diameter can be adjusted by the stress applied to the composition when emulsifying.
本発明の乳化組成物に含まれる油剤は、特に限定されず、液体油脂、固体油脂、ロウ、炭化水素油、高級脂肪酸、高級アルコール、エステル油、シリコーン油等を含有することができる。 The oil agent contained in the emulsified composition of the present invention is not particularly limited, and may contain liquid fats and oils, solid fats and oils, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, ester oils, silicone oils, and the like.
液体油脂としては、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、メドウフォーム油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等が挙げられる。 Examples of liquid fats and oils include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern oil, castor oil, linseed oil , Safflower oil, cottonseed oil, eno oil, meadowfoam oil, soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, sinagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, And glycerin triisopalmitate.
固体油脂としては、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等が挙げられる。 As solid oils and fats, cacao butter, coconut oil, horse fat, hardened coconut oil, palm oil, tallow, sheep butter, hardened tallow, palm kernel oil, lard, beef bone fat, mocro kernel oil, hardened oil, beef leg fat , Molle, hardened castor oil and the like.
ロウ類としては、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル等が挙げられる。 The waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nuka wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, and jojo. Barrow, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, and the like.
炭化水素油としては、流動パラフィン、オゾケライト、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス、水添ポリオレフィン(炭素数6〜20)等が挙げられる。 Examples of the hydrocarbon oil include liquid paraffin, ozokerite, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, hydrogenated polyolefin (having 6 to 20 carbon atoms), and the like.
高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン(ベヘニン)酸、12−ヒドロキシステアリン酸、ウンデシレン酸、トール酸等が挙げられる。 Examples of the higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic (beheninic) acid, 12-hydroxystearic acid, undecylenic acid, and tolic acid.
高級アルコールとしては、例えば、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、バチルアルコール、ミリスチルアルコール、セトステアリルアルコール等が挙げられる。 Examples of the higher alcohol include cetyl alcohol, stearyl alcohol, behenyl alcohol, butyl alcohol, myristyl alcohol, and cetostearyl alcohol.
エステル油としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、イソノナン酸イソニル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、ステアリン酸スクロース、オレイン酸スクロース、12−ヒドロキシステアリル酸コレステリル、ジ−2−エチルヘキシル酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N−アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキシル酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキシル酸ペンタンエリスリトール、トリ−2−エチルヘキシル酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2−エチルヘキサノエート、2−エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ−2−ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オイル、セトステアリルアルコール、アセトグリセライド、パルミチン酸2−ヘプチルウンデシル、パルミチン酸セチル、アジピン酸ジイソブチル、N−ラウロイル−L−グルタミン酸−2−オクチルドデシルエステル、アジピン酸ジ−2−ヘプチルウンデシル、エチルラウレート、セバチン酸ジ−2−エチルヘキシル、ミリスチン酸2−ヘキシルデシル、パルミチン酸2−ヘキシルデシル、アジピン酸2−ヘキシルデシル、セバチン酸ジイソプロピル、コハク酸2−エチルヘキシル、酢酸エチル、酢酸ブチル、酢酸アミル、クエン酸トリエチル、メトキシケイヒ酸エチルヘキシル等が挙げられる。 Ester oils include isopropyl myristate, cetyl octanoate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyl octanoate, isonyl isononanoate, cetyl lactate , Myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, sucrose stearate, sucrose oleate, cholesteryl 12-hydroxystearylate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, monoisostearate N- Alkyl glycol, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate Trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, pentaneerythritol tetra-2-ethylhexylate, glycerin tri-2-ethylhexylate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2 -Ethylhexyl palmitate, glyceryl trimmyristate, glyceride tri-2-heptylundecanoate, methyl ester of castor oil fatty acid, oleic acid oil, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, cetyl palmitate, adipic acid Diisobutyl, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, sebac Di-2-ethylhexyl acid, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate And ethylhexyl methoxycinnamate.
シリコーン油としては、ジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン、ジフェニルシロキシフェニルトリメチコン等の鎖状ポリシロキサンや、ペンタシロキサン、デカメチルポリシロキサン、ドデカメチルポリシロキサン、テトラメチルテトラハイドロジェンポリシロキサンなどの環状ポリシロキサン等が挙げられる。 Examples of the silicone oil include chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, diphenylsiloxyphenyltrimethicone, pentasiloxane, decamethylpolysiloxane, dodecamethylpolysiloxane, and tetramethyltetrahydrogen. Cyclic polysiloxanes such as genpolysiloxane are exemplified.
本発明の乳化組成物は、発明の効果を損なわない範囲において通常皮膚外用剤に用いられる任意成分を含んでいてもよい。かかる任意成分としては、例えば、キサンタンガム、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸,ローカストビーンガム,サクシノグルカン,カロニン酸,キチン,キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、アクリル酸ナトリウムグラフトデンプン、ステアロキシヒドロキシプロピルメチルセルロース、ベントナイト等が挙げられ、中でも、キサンタンガム等の水溶性多糖類、寒天、アクリル酸ナトリウムグラフトデンプン、ステアロキシヒドロキシプロピルメチルセルロース等の増粘剤、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、表面処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、表面処理されていても良い、酸化コバルト、群青、紺青、酸化亜鉛の無機顔料類、表面処理されていても良い、酸化鉄二酸化チタン焼結体等の複合顔料、表面処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類、レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類、ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類、エタノール、イソプロパノール等の低級アルコール類、ビタミンA又はその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2又はその誘導体,ビタミンB12,ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類、パラアミノ安息香酸、パラアミノ安息香酸モノグリセリンエステル、N,N−ジプロポキシパラアミノ安息香酸エチルエステル、N,N−ジエトキシパラアミノ安息香酸エチルエステル、N,N−ジメチルパラアミノ安息香酸エチルエステル、N,N−ジメチルパラアミノ安息香酸ブチルエステル、N,N−ジメチルパラアミノ安息香酸エチルエステル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル等の安息香酸誘導体;ホモメンチル−N−アセチルアントラニレート等のアントラニル酸誘導体;サリチル酸及びそのナトリウム塩、アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p−イソプロパノールフェニルサリシレート等のサリチル酸誘導体;オクチルシンナメート、エチル−4−イソプロピルシンナメート、メチル−2,5−ジイソプロピルシンナメート、エチル−2,4−ジイソプロピルシンナメート、メチル−2,4−ジイソプロピルシンナメート、プロピル−p−メトキシシンナメート、イソプロピル−p−メトキシシンナメート、イソアミル−p−メトキシシンナメート、2−エチルヘキシルp−メトキシシンナメート(メトキシケイ皮酸エチルヘキシル、パラメトキシケイ皮酸オクチル)、2−エトキシエチル−p−メトキシシンナメート(シノキサート)、シクロヘキシル−p−メトキシシンナメート、エチル−α−シアノ−β−フェニルシンナメート、2−エチルヘキシル2−シアノ−3,3−ジフェニルアクリラート(オクトクリレン)、グリセリルモノ−2−エチルヘキサノイル−ジパラメトキシシンナメート、フェルラ酸及びその誘導体等のケイ皮酸誘導体;2,4−ジヒドロキシベンゾフェノン、2,2’−ジヒドロキシ−4−メトキシベンゾフェノン、2,2’−ジヒドロキシ−4,4’−ジメトキシベンゾフェノン、2,2’,4,4’−テトラヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン(オキシベンゾン−3)、2−ヒドロキシ−4−メトキシ−4’−メチルベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−フェニルベンゾフェノン、2−エチルヘキシル−4’−フェニル−ベンゾフェノン−2−カルボキシレート、2−ヒドロキシ−4−n−オクトキシベンゾフェノン、4−ヒドロキシ−3−カルボキシベンゾフェノン等のベンゾフェノン誘導体;3−(4’−メチルベンジリデン)−d,l−カンファー、3−ベンジリデン−d,l−カンファー;2−フェニル−5−メチルベンゾキサゾール;2,2’−ヒドロキシ−5−メチルフェニルベンゾトリアゾール;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール;2−(2’−ヒドロキシ−5’−メチルフェニルベンゾトリアゾール;ジベンザラジン;ジアニソイルメタン;5−(3,3−ジメチル−2−ノルボルニリデン)−3−ペンタン−2−オン;4−t−ブチルメトキシジベンゾイルメタン等のジベンゾイルメタン誘導体;オクチルトリアゾン;ウロカニン酸及びウロカニン酸エチル等のウロカニン酸誘導体;2−(2'−ヒドロキシ−5'−メチルフェニル)ベンゾトリアゾール、1−(3,4−ジメトキシフェニル)−4,4−ジメチル−1,3−ペンタンジオン、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2−エチルヘキシル等のヒダントイン誘導体;フェニルベンズイミダソゾールスルホン酸、テレフタリリデンジカンフルスルホン酸、ドロメトリゾールトリシロキサン、アントラニル酸メチル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、ルチン及びその誘導体、オリザノール及びその誘導体などの紫外線吸収剤が好ましいものとして挙げられる。 The emulsified composition of the present invention may contain optional components that are usually used in external preparations for the skin within a range that does not impair the effects of the present invention. Such optional components include, for example, xanthan gum, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, Glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, kerato sulfate, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, Carboxymethyl chitin, agar, polyvinyl alcohol, polyvinyl pyrrolidone, carboxy vinyl Polymers, sodium polyacrylate, polyethylene glycol, sodium acrylate grafted starch, stearoxyhydroxypropylmethylcellulose, bentonite, etc., among which water-soluble polysaccharides such as xanthan gum, agar, sodium acrylate grafted starch, stearyloxyhydroxypropyl Thickeners such as methylcellulose, moisturizing components such as sodium pyrrolidonecarboxylate, lactic acid, and sodium lactate; mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, and silicic anhydride (silica, which may be surface-treated) ), Powders such as aluminum oxide and barium sulfate, inorganic pigments such as cobalt oxide, ultramarine, navy blue and zinc oxide which may be surface-treated, iron oxide titanium dioxide sintered which may be surface-treated Pigments which may be surface-treated, such as titanium mica, fish phosphor foil, bismuth oxychloride, etc., pearlescent agents which may be laked, red 202, red 228, red 226, yellow 4 No., Blue No. 404, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Organic pigments such as Red 204, polyethylene powder, polymethyl methacrylate, nylon powder, organic powders such as organopolysiloxane elastomers, lower alcohols such as ethanol and isopropanol, vitamin A or its derivatives, and vitamin B6 hydrochloride , Vitamin B6 tripalmitate, Vitamin B6 dioctanoate, Vitamin B2 or its derivatives, Vitamin B12, Vita Vitamin B such as min B15 or a derivative thereof, vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, pantethine, pyrroloquinoline quinone and other vitamins , Paraaminobenzoic acid, paraaminobenzoic acid monoglycerin ester, N, N-dipropoxyparaaminobenzoic acid ethyl ester, N, N-diethoxyparaaminobenzoic acid ethyl ester, N, N-dimethylparaaminobenzoic acid ethyl ester, N, N Benzoic acid derivatives such as N-dimethylparaaminobenzoic acid butyl ester, N, N-dimethylparaaminobenzoic acid ethyl ester, diethylaminohydroxybenzoylhexylbenzoate and the like; antacids such as homomenthyl-N-acetylanthranilate and the like Nylic acid derivatives; salicylic acid and its sodium salts, amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, salicylic acid derivatives such as p-isopropanol phenyl salicylate; octyl cinnamate, ethyl-4-isopropyl cinnamate , Methyl-2,5-diisopropylcinnamate, ethyl-2,4-diisopropylcinnamate, methyl-2,4-diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p -Methoxycinnamate, 2-ethylhexyl p-methoxycinnamate (ethylhexyl methoxycinnamate, octyl paramethoxycinnamate), 2-ethoxy Ciethyl-p-methoxycinnamate (cinoxate), cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (octocrylene), glyceryl Cinnamic acid derivatives such as mono-2-ethylhexanoyl-diparamethoxycinnamate, ferulic acid and derivatives thereof; 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′- Dihydroxy-4,4'-dimethoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone (oxybenzone-3), 2-hydroxy-4-methoxy-4'-methyl Benzophenone, 2-hydro C-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy- Benzophenone derivatives such as 3-carboxybenzophenone; 3- (4'-methylbenzylidene) -d, l-camphor; 3-benzylidene-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2 ' -Hydroxy-5-methylphenylbenzotriazole; 2- (2'-hydroxy-5'-t-octylphenyl) benzotriazole; 2- (2'-hydroxy-5'-methylphenylbenzotriazole; dibenzarazine; dianisoylmethane 5- (3,3-dimethyl-2- Norbornylidene) -3-pentan-2-one; dibenzoylmethane derivatives such as 4-t-butylmethoxydibenzoylmethane; octyltriazone; urocanic acid derivatives such as urocanic acid and ethyl urocanate; 2- (2′-hydroxy Hydantoin derivatives such as -5'-methylphenyl) benzotriazole, 1- (3,4-dimethoxyphenyl) -4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidine propionate; Phenylbenzimidazozole sulfonic acid, terephthalidene dicane fursulfonic acid, drometrizole trisiloxane, methyl anthranilate, bisethylhexyloxyphenol methoxyphenyl triazine, rutin and its derivatives, oryzanol and its derivatives Ultraviolet absorbents such as derivatives as preferred.
本発明の乳化組成物は、構成成分を常法により混合することにより製造することができる。 The emulsified composition of the present invention can be produced by mixing constituent components by a conventional method.
本発明の乳化組成物は皮膚外用剤の形態とすることが好ましい。皮膚外用剤としては、化粧料、医薬品、医薬部外品などが挙げられる。 The emulsion composition of the present invention is preferably in the form of a skin external preparation. Examples of skin external preparations include cosmetics, pharmaceuticals, and quasi-drugs.
<2>防腐方法
本発明は、低分子界面活性剤を実質的に含まない、いわゆる界面活性剤フリーの乳化組成物の防腐方法にも関する。本発明の防腐方法は、乳化組成物に、(A)の多価アルコール、(B)防腐剤及び(C)粉体を添加することを特徴とする。
なお、「乳化組成物に、・・・添加する」ことには、調製済みの乳化組成物に(A)〜(C)を添加する形態だけでなく、乳化組成物の調製時に(A)〜(C)を添加する形態も含まれる。
上記<1>に記載した本発明の乳化組成物の実施の形態に関する事項は、本発明の防腐方法にそのまま適用できる。
<2> Preservation method The present invention also relates to a method of preserving a so-called surfactant-free emulsified composition substantially free of a low-molecular surfactant. The preservation method of the present invention is characterized by adding the polyhydric alcohol (A), the preservative (B) and the powder (C) to the emulsion composition.
In addition, "adding to an emulsion composition" means not only a form in which (A) to (C) are added to a prepared emulsion composition but also (A) to (A) to when an emulsion composition is prepared. The form to which (C) is added is also included.
The matters relating to the embodiment of the emulsified composition of the present invention described in the above <1> can be applied as they are to the preservative method of the present invention.
<製造例1>
室温(25℃)下、表1に示す(イ)水相成分に(ロ)粉体成分を分散し、そこへ(ハ)油相成分を撹拌しながら投入し乳化することで、実施例及び比較例の乳化組成物(ピッカリングエマルション)を製造した。
なお、疎水化シリカは、シリカ微粒子(AEROSIL社製)とトリメチルシリル疎水化処理剤を混合することにより得られたものを使用した。
<Production Example 1>
At room temperature (25 ° C.), (b) the powder component was dispersed in the (a) aqueous phase component shown in Table 1, and (c) the oil phase component was added thereto with stirring to emulsify the mixture. An emulsified composition (Pickering emulsion) of a comparative example was produced.
The hydrophobized silica used was obtained by mixing silica fine particles (manufactured by AEROSIL) and a trimethylsilyl hydrophobizing agent.
<試験例1>防腐性測定
実施例及び比較例の乳化組成物について、防腐剤への抵抗力が強い真菌(アスペルギルス・ニガー(Aspergillus niger))に対しての抗菌性を調べた。すなわち、サブローデキストロース寒天培地(SDA培地)の平板培地に乳化組成物を0.1ml塗抹した後、白金耳で前記真菌を接種した。接種後1日で発生したコロニーの数を基準に、以下に示すように、防腐性について3段階評価を行った。なお、コロニー数が以下の3段階の範囲の何れに属するかについては、コロニー数の標準写真と検体の状況を比較することで判別した。結果を表2に示す。
(防腐性)
○・・・0〜1000
△・・・1001〜3000
×・・・3001以上
<Test Example 1> Measurement of antiseptic properties The emulsified compositions of Examples and Comparative Examples were examined for antibacterial properties against fungi (Aspergillus niger) having a strong resistance to an antiseptic. That is, after 0.1 ml of the emulsified composition was spread on a plate medium of Sabouraud dextrose agar medium (SDA medium), the fungus was inoculated with a platinum loop. Based on the number of colonies that occurred one day after the inoculation, a three-stage evaluation was performed on the preservability as shown below. Which of the following three stages the colony number belongs to was determined by comparing the standard photograph of the colony number and the state of the specimen. Table 2 shows the results.
(Antiseptic)
○ ・ ・ ・ 0-1000
△ ・ ・ ・ 1001-3000
× ・ ・ ・ 3001 or more
<試験例2>安定性試験
実施例及び比較例の乳化組成物を常温で1週間静置した後の状態を観察し、以下の基準により乳化組成物の安定性を評価した。結果を表2に示す。
(安定性)
○・・・油相と水相の分離が全く見られない
△・・・油相と水相の一部が分離している
×・・・油相と水相が完全に分離している
<Test Example 2> Stability test The state of the emulsion compositions of Examples and Comparative Examples after standing at room temperature for one week was observed, and the stability of the emulsion compositions was evaluated according to the following criteria. Table 2 shows the results.
(Stability)
○ ・ ・ ・ No separation of oil phase and water phase is observed at all △ ・ ・ ・ Part of oil phase and water phase are separated × ・ ・ ・ Oil phase and water phase are completely separated
表2に示すように、(B)の防腐剤を含むが(A)の多価アルコールを含まない比較例1の乳化組成物は、防腐性に劣るものであった。一方、(A)の多価アルコール及び(B)防腐剤を含む実施例の乳化組成物は何れも防腐性に優れるものであった。
この結果は、界面活性剤フリーの乳化組成物において、(A)の多価アルコールと(B)の防腐剤を併用することで、その防腐性を向上させることができることを示している。
As shown in Table 2, the emulsified composition of Comparative Example 1 containing the preservative of (B) but not of the polyhydric alcohol of (A) was inferior in preservability. On the other hand, the emulsified compositions of Examples containing the polyhydric alcohol (A) and the preservative (B) were all excellent in preservability.
This result indicates that in the surfactant-free emulsified composition, the preservative property can be improved by using the polyhydric alcohol (A) and the preservative (B) in combination.
また、同量の(A)の多価アルコール及び(B)防腐剤を含むにも関わらず、ピッカリングエマルションである実施例1の乳化組成物は、いわゆる高分子乳化組成物である比較例2の乳化組成物と比較して、防腐性及び安定性に優れていた。
この結果は、実施例の乳化組成物における優れた防腐性及び安定性は、(A)の多価アルコール、(B)防腐剤及び(C)粉体の相乗効果によってもたらされるものであることを示している。
Further, despite containing the same amounts of the polyhydric alcohol (A) and the preservative (B), the emulsion composition of Example 1 which is a Pickering emulsion is a so-called polymer emulsion composition, Comparative Example 2 As compared with the emulsified composition of Example 1.
This result indicates that the excellent preservative property and stability in the emulsified compositions of the examples are obtained by the synergistic effect of the polyhydric alcohol (A), the preservative (B) and the powder (C). Is shown.
また、表2に示す通り、1,3−ブチレングリコールを3質量%以上含む実施例1〜6の乳化組成物は、1,3−ブチレングリコールの含有量が比較的少ない実施例7(1質量%)及び実施例8(0質量%)の乳化組成物に比して安定性に優れている。
この結果は、(A)の多価アルコール及び(B)の防腐剤を含むピッカリングエマルションにおいて、(D)の多価アルコールを用いることで、安定性を向上させることができることを示している。
Also, as shown in Table 2, the emulsified compositions of Examples 1 to 6 containing 1,3-butylene glycol in an amount of 3% by mass or more contained Example 7 (1% by mass) having a relatively small amount of 1,3-butylene glycol. %) And the emulsion composition of Example 8 (0% by mass).
This result indicates that the stability can be improved by using the polyhydric alcohol (D) in the Pickering emulsion containing the polyhydric alcohol (A) and the preservative of (B).
<製造例2>
製造例1と同一の疎水化シリカを用いて、製造例1と同様の手法により、表3の処方のピッカリングエマルション(参考例)を製造した。そして、参考例のピッカリングエマルションを走査型電子顕微鏡により観察した。電子顕微鏡像を図1に示す。
<Production Example 2>
Using the same hydrophobized silica as in Production Example 1, a Pickering emulsion having the formulation shown in Table 3 (Reference Example) was produced in the same manner as in Production Example 1. Then, the Pickering emulsion of Reference Example was observed with a scanning electron microscope. An electron microscope image is shown in FIG.
参考例のピッカリングエマルションにおけるシリカの二次粒子径を図1に基づき算出した。その結果、シリカの平均二次粒子径は50nm以下であった。
参考例と実施例のピッカリングエマルションは、同一の疎水化シリカを用い、同一の方法で製造したものである。したがって、参考例のピッカリングエマルションの走査型電子顕微鏡による観察結果は、実施例のピッカリングエマルションにおける疎水化シリカの平均二次粒子径も50nm以下であることを示している。
The secondary particle diameter of silica in the Pickering emulsion of Reference Example was calculated based on FIG. As a result, the average secondary particle diameter of the silica was 50 nm or less.
The Pickering emulsions of the reference example and the example were produced using the same hydrophobized silica and by the same method. Therefore, the result of observation of the Pickering emulsion of the reference example with a scanning electron microscope shows that the average secondary particle diameter of the hydrophobized silica in the Pickering emulsion of the example is also 50 nm or less.
本発明は化粧料に応用することができる。 The present invention can be applied to cosmetics.
Claims (9)
9. The preservative method according to claim 8, further comprising adding (D) a polyhydric alcohol having 4 or less carbon atoms not containing a cyclic structure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018183070A JP7232605B2 (en) | 2018-09-28 | 2018-09-28 | Antiseptic emulsified composition and antiseptic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018183070A JP7232605B2 (en) | 2018-09-28 | 2018-09-28 | Antiseptic emulsified composition and antiseptic method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020050628A true JP2020050628A (en) | 2020-04-02 |
JP7232605B2 JP7232605B2 (en) | 2023-03-03 |
Family
ID=69995821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018183070A Active JP7232605B2 (en) | 2018-09-28 | 2018-09-28 | Antiseptic emulsified composition and antiseptic method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7232605B2 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1053510A (en) * | 1996-05-27 | 1998-02-24 | Shiseido Co Ltd | Composition for external use |
JP2002308720A (en) * | 2001-04-16 | 2002-10-23 | Pola Chem Ind Inc | Skin-protecting cosmetic |
JP2003335615A (en) * | 2002-05-20 | 2003-11-25 | Kose Corp | Water in oil type external preparation |
JP2004352688A (en) * | 2003-05-30 | 2004-12-16 | Kao Corp | Antiseptic agent |
JP2008291026A (en) * | 2007-04-26 | 2008-12-04 | Shiseido Co Ltd | Oil-in-water type emulsified composition and method for producing the same |
JP2013049668A (en) * | 2011-08-02 | 2013-03-14 | Shiseido Co Ltd | Oil-in-water type emulsified cosmetic |
JP2013095754A (en) * | 2011-11-04 | 2013-05-20 | Symrise Ag | Synergistically acting, three-component antibacterial mixture |
-
2018
- 2018-09-28 JP JP2018183070A patent/JP7232605B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1053510A (en) * | 1996-05-27 | 1998-02-24 | Shiseido Co Ltd | Composition for external use |
JP2002308720A (en) * | 2001-04-16 | 2002-10-23 | Pola Chem Ind Inc | Skin-protecting cosmetic |
JP2003335615A (en) * | 2002-05-20 | 2003-11-25 | Kose Corp | Water in oil type external preparation |
JP2004352688A (en) * | 2003-05-30 | 2004-12-16 | Kao Corp | Antiseptic agent |
JP2008291026A (en) * | 2007-04-26 | 2008-12-04 | Shiseido Co Ltd | Oil-in-water type emulsified composition and method for producing the same |
JP2013049668A (en) * | 2011-08-02 | 2013-03-14 | Shiseido Co Ltd | Oil-in-water type emulsified cosmetic |
JP2013095754A (en) * | 2011-11-04 | 2013-05-20 | Symrise Ag | Synergistically acting, three-component antibacterial mixture |
Also Published As
Publication number | Publication date |
---|---|
JP7232605B2 (en) | 2023-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6321105B2 (en) | Oil-in-water emulsified cosmetic | |
WO2010087354A1 (en) | Water-in-oil-type emulsion sunscreen cosmetic | |
JP5913411B2 (en) | Oil-in-water emulsified cosmetic | |
JP2023139308A (en) | Visible light-translucent pickering emulsion | |
JP4601031B2 (en) | W / O / W emulsified cosmetics | |
JP5546140B2 (en) | Oil-in-water emulsion composition | |
JP2009013100A (en) | Skin preparation for external use of oil-in-water type emulsion | |
TW202042783A (en) | External preparation for skin and method for improving ultraviolet protection effect | |
JP5124099B2 (en) | Oil-in-water emulsifier type cosmetic | |
JP2024045107A (en) | W/O type Pickering emulsion and cosmetic preparation containing same | |
WO2017130655A1 (en) | α-GEL FORMATION COMPOSITION AND α-GEL COMPOSITION | |
JP2000219607A (en) | Composition for external use | |
JP6563181B2 (en) | Sunscreen skin preparation | |
JP2020050628A (en) | Antiseptic emulsion composition and antiseptic method | |
JP2019202962A (en) | Pickering emulsion containing acrylic polymer | |
JP6622086B2 (en) | Oil-in-water emulsified composition and cosmetic | |
JP2012102060A (en) | Gel-like composition | |
JP4771644B2 (en) | Emulsifying sunscreen cosmetics | |
JP2008255044A5 (en) | ||
JP7182977B2 (en) | Oil-in-water Pickering emulsion containing light shielding powder | |
JP7398917B2 (en) | W/O/W type emulsion composition | |
JP2015030723A (en) | Emulsifier type sunscreen cosmetic | |
US11458079B2 (en) | Sunscreen cosmetic | |
JP7157554B2 (en) | External composition containing polymer and metal oxide powder | |
JP7232861B2 (en) | Method for modifying powder particle surface |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210729 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220413 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220701 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221025 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221128 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230220 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7232605 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |